Arch Pharmalabs Limited
- Current price
- ₹85.00 Per share
- Market cap
- ₹1,330 Cr Total valuation
- P/E ratio
- 10.9 Price to earnings
- Sector
- Healthcare & Pharmaceuticals Industry
About Arch Pharmalabs Limited
Arch Pharmalabs Limited operates in the Healthcare & Pharmaceuticals sector. Its shares are not listed on stock exchanges like NSE or BSE and are traded through private transactions. On InvestShare, Arch Pharmalabs Limited shares are currently priced at ₹85.00 per share.
Shares in private companies can offer exposure before a potential IPO. They carry higher risk than listed stocks, so proper research and a long-term outlook are important.
Arch Pharmalabs Limited share FAQs
What is the Arch Pharmalabs Limited share price today?
The current Arch Pharmalabs Limited share price on InvestShare is ₹85.00 per share. Private-market share prices are indicative and may change.
How can I buy Arch Pharmalabs Limited shares?
Complete a simple KYC on InvestShare with your PAN, Aadhaar and demat account details, then place a buy request for Arch Pharmalabs Limited. After confirmation and settlement, the shares are transferred to your demat account through an off-market transaction.
Is a demat account required to buy Arch Pharmalabs Limited shares?
Yes, a demat account is required to hold Arch Pharmalabs Limited shares. The shares are credited to your demat account through an off-market transfer.
Key data & fundamentals
About Arch Pharmalabs Limited
ARCH PHARMALABS LIMITED, a Pharmaceutical Company aligned across two business verticals viz. Products and Services. Company’s Products business comprises manufacturing and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets.
- Indicative price
- ₹85.00
- Lot size
- 250
- 52 week high
- —
- 52 week low
- —
- Market cap
- ₹1,330 Cr
- No. of shares
- 15,64,80,000
- P/E ratio
- 10.9
- P/B ratio
- 1.57
- ROE
- 14.57 %
- Book value
- ₹54.16
- Face value
- ₹10
- ISIN
- INE182F01017
- PAN
- AACCM0306Q
Indicative price history
Financial statements
- Revenue · FY23
- 1,341 ₹ Cr ▲Up2%
- EBITDA · FY23
- 180 ₹ Cr ▲Up2%
- Profit before tax · FY23
- 122 ₹ Cr ▲Up135%
- Net profit (PAT) · FY23
- 122 ₹ Cr ▲Up135%
- Operating margin · FY23
- 13.42% ▼Down1%
- EPS · FY23
- ₹7.8 ▲Up128%
| Particulars | FY21 | FY22 | FY23 | YoY |
|---|---|---|---|---|
| Revenue | 706 | 1,309 | 1,341 | ▲Up2% |
| EBITDA | -725 | 177 | 180 | ▲Up2% |
| OPM (%) | -102.69 | 13.52 | 13.42 | ▼Down1% |
| PBT | 1,869 | 52 | 122 | ▲Up135% |
| PAT | 1,869 | 52 | 122 | ▲Up135% |
| EPS (₹) | 123.03 | 3.42 | 7.8 | ▲Up128% |
| Particulars | FY21 | FY22 | FY23 | YoY |
|---|---|---|---|---|
| Share capital | 151.92 | 151.92 | 156.48 | ▲Up3% |
| Reserves | 81 | 452 | 681 | ▲Up51% |
| Borrowings | 1,139 | 856 | 850 | ▼Down1% |
| Total assets | 2,362 | 2,318 | 2,415 | ▲Up4% |
| Total liabilities | 2,362 | 2,318 | 2,415 | ▲Up4% |
| Investments | 22 | 15 | 13 | ▼Down13% |
| Particulars | FY21 | FY22 | FY23 | YoY |
|---|---|---|---|---|
| CFO | 278 | 115.34 | 42.49 | ▼Down63% |
| CF investing | -8 | -10.67 | -1.39 | ▲Up87% |
| CF financing | -270 | -105.13 | -41.09 | ▲Up61% |
| Net cash | 0 | -0.46 | 0.01 | ▲Up102% |
| Cash at end | 3 | 2.54 | 2.77 | ▲Up9% |